| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |